A shorter version of this column has been published by Axios. We have never seen a year in which health spending actually goes down. Now the seemingly impossible is happening, but the reason – COVID-19 – makes it both anomalous and more tragic than a cause for celebration. + Year-to-date spending on health services is
Several COVID-19 vaccines are now in phase 3 trials, and $10 billion in government money has been invested in the research, development, manufacturing, and distribution of vaccines. As part of this effort, the federal government has paid in advance for hundreds of millions of doses of multiple COVID-19 vaccines and, in some cases, has the
With hopes that a COVID-19 vaccine or vaccines will be proven safe and effective soon, state and local public health authorities will play a critical role in ensuring the efficient distribution and administration of the vaccine. To assess the readiness of these local governments to take on these responsibilities, KFF reviewed the preliminary vaccine distribution
A new chart collection examines what we know about the cost of common health services in the U.S. The analysis shows that costs for many common health services have risen more rapidly than inflation; for example, the average cost of hospital admission among large employer plans increased by about $10,000 (68%) between 2008 and 2018.
Health insurance can be expensive, and is therefore often out of reach for lower and moderate income families. To make coverage obtainable for families that otherwise could not afford it and to encourage broad participation in health insurance, the Affordable Care Act (ACA) includes provisions to lower premiums and out-of-pocket costs for people with low
In this perspective published by the Washington Post, KFF Executive Vice President for Health Policy Larry Levitt explains why the popular Affordable Care Act provisions that ensure people with pre-existing conditions can access affordable health insurance can’t easily be preserved if other related provisions are overturned.
A new KFF brief looks at where COVID-19 falls as a leading cause of death in the U.S. compared to similarly large and wealthy countries. The analysis finds that COVID-19 mortality rates are the third leading cause of death in the U.S., a ranking shared by only one peer country, Belgium. In several other peer
A new KFF analysis examines leading causes of death and mortality rates in the United States and comparable countries. The U.S. has a higher COVID-19 mortality rate than many of its peer countries, with COVID-19 ranking as the nation’s third-leading cause of death in 2020, behind only heart disease and cancer. Among similarly large and
In his latest Axios column, Drew Altman discusses how this election year health isn’t a single issue issue – but several – and Joe Biden has the edge over President Trump on all of them, even as opposition to the ACA remains popular with Trump’s base.
Approximately seven months after the coronavirus sparked social distancing measures and concerns about hospital capacity, new medical records data help shed light on the magnitude of the drop in hospital admissions and the more recent rebound in hospitalizations. These new data provide additional information to help assess the economic impact of the COVID-19 pandemic on
As the Senate considers Judge Amy Coney Barrett’s nomination to the Supreme Court, the October KFF Health Tracking Poll finds a large majority (79%) of the public do not want the Court to overturn the Affordable Care Act’s protections for people with pre-existing medical conditions, up 17 percentage points since last year when 62% held
Key Findings The confirmation hearings for Judge Barrett, President Trump’s appointment to fill the Supreme Court seat previously held by Justice Ginsburg, are underway this week and the future of the ACA’s protections for people with pre-existing conditions have been front-and-center. The latest KFF Health Tracking Poll finds a large majority of the public –
As the coronavirus pandemic enters its eighth month, we are still facing uncertainty about what the long-term impact of the crisis will be for the health sector, and for patients. However, the extent to which costs grow, and how the burden is distributed across payers, programs, individuals, outcomes, and geography are still very much unknown.
The high cost of prescription drugs continues to be a top concern for the public. Policymakers at the federal and state level are pursuing a range of options to lower drug prices for Americans, one of which would allow for the safe importation of prescription drugs from Canada and other countries, based on evidence showing
U.S. Supreme Court decisions shape health policy in important ways. The nomination of Judge Amy Coney Barrett, if confirmed, is expected to establish a solid 6:3 conservative majority that could affect case outcomes in several areas. This issue brief considers the potential implications of a reconfigured Court for health policy issues, including those already on
This annual survey of employers provides a detailed look at trends in employer-sponsored health coverage, including premiums, employee contributions, cost-sharing provisions, offer rates, wellness programs, and employer practices. The 2020 survey included 1,765 interviews with non-federal public and private firms. Annual premiums for employer-sponsored family health coverage reached $21,342 this year, up 4% from last
San Francisco – Annual family premiums for employer-sponsored health insurance rose 4% to average $21,342 this year, according to the 2020 benchmark KFF Employer Health Benefits Survey. On average, workers this year are contributing $5,588 toward the cost of family coverage, with employers paying the rest. The survey was conducted from January to July as
Since 1999, the Employer Health Benefits Survey has documented trends in the employer-sponsored health insurance market. This year, 1,765 private and non-federal public employers with three or more employees completed the full survey. Among other topics, the survey asks firms for the premium or full per-person cost of their health coverage as well as the
The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400 Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff Filling the need for trusted information on national health issues,
A new chart collection examines what we know about public health spending in the U.S. and comparable countries. The chart collection explores high-level trends in spending on public health and prevention in the U.S., and finds that while the U.S. spends more than most comparable countries on preventive care, the share of total U.S. health
A new KFF issue brief compares the main drivers of health spending in the United States and other large, wealthy countries, and finds that the cost of inpatient and outpatient care – much more so than prescription drugs or administrative costs – drives high per capita health spending in the U.S. In 2018, the U.S. spent